Rising Prevalence Of Autoimmune Diseases Fueling Growth In The Is Supporting Expansion In The Genome Sequencing Market

Global Genome Sequencing Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Genome Sequencing Market Projected To Reach By 2030?

The genome sequencing market size has experienced swift expansion in recent years. It is anticipated to increase from $11.78 billion in 2025 to $14.04 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.2%. In the historical period, this growth can be attributed to elements such as the limited access to advanced sequencing systems, a reliance on conventional Sanger sequencing, the proliferation of genomics research initiatives, enhanced government financial support for genome projects, and a heightened awareness of personalized medicine.

The genome sequencing market size is anticipated to experience rapid expansion in the upcoming years. It is forecasted to grow to $28.07 billion in 2030, achieving a compound annual growth rate (CAGR) of 18.9%. The drivers for this growth during the forecast period include the development of next-generation sequencing systems, the expansion of bioinformatics platforms, the increasing adoption of precision medicine programs, a rise in collaborations between biotech and pharmaceutical companies, and the growth in genomic data storage and management solutions. Major trends expected in this period encompass the increasing integration of next-generation sequencing (NGS) technologies, a rising demand for precision medicine and personalized therapies, the broadening of bioinformatics and data analysis services, an increase in environmental and microbiome genomics applications, and the incorporation of custom genome sequencing solutions in research.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19484&type=smp

What Key Drivers Are Fueling The Growth Of The Genome Sequencing Market?

The escalating incidence of cancer is anticipated to fuel the expansion of the genome sequencing market moving forward. Cancer is a collection of illnesses marked by the unregulated proliferation and dissemination of atypical cells, which can prove fatal if left unmanaged. The rise in cancer cases stems from various elements, including an aging populace, lifestyle choices, environmental exposures, and genetic predispositions. Genome sequencing aids in uncovering genetic mutations and susceptibilities to cancer, thereby enabling prompt identification and customized treatment approaches. It further uncovers inherited cancer risks and supports the monitoring of cancerous cell progression. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, new cancer cases are projected to reach over 35 million by 2050, representing a 77% increase compared to 20 million cases in 2022. Consequently, the growing prevalence of cancer is propelling the development of the genome sequencing market.

Which Segments Define The Genome Sequencing Market Segment Structure?

The genome sequencing market covered in this report is segmented –

1) By Product: Consumables, Systems And Software, Services

2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction, Purification, Other Technologies

3) By Applications: Diagnostics, Drug Discovery, Precision Medicine, Environmental Genomics, Research, Other Applications

4) By End-User: Hospitals And Clinics, Biotechnology And Pharmaceutical Companies, Contract Research Organizations (CROs), Government, Research Centers, Academic And Government Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents And Kits, Sequencing Chips And Plates, Sample Preparation Products, Library Preparation Kits, DNA And RNA Extraction Kits

2) By Systems And Software: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Bioinformatics Software And Analysis Tools, Data Management And Storage Solutions, Laboratory Information Management Systems (LIMS)

3) By Services: Sequencing Services, Bioinformatics Analysis Services, Consultation And Support Services, Custom Genome Sequencing Solutions, Sample Collection And Preparation Services.

What Trends Are Shaping The Future Of The Genome Sequencing Market?

Major companies operating in the genome sequencing market are concentrating on creating sophisticated solutions, such as next-generation sequencing (NGS)-based assays, to improve the precision of genetic analysis and support personalized medicine strategies. NGS-based assays are defined as cutting-edge genomic technologies designed for the rapid and high-throughput sequencing of DNA or RNA for genetic material analysis. NGS facilitates the concurrent sequencing of millions of DNA or RNA fragments, thereby producing vast amounts of data efficiently and at a lower cost. For instance, in April 2023, Centogene N.V., a Germany-based provider of genetic diagnostics for rare diseases, launched CentoGenome, an enhanced Next Generation Sequencing (NGS)-based assay. This assay provides continuous diagnostic assistance, including proactive diagnosis confirmation and reclassification programs without additional charges, thus ensuring ongoing patient care and precise disease management. By employing a PCR-free methodology, CentoGenome mitigates bias and boosts sequencing quality, resulting in superior coverage of challenging genomic regions and deeper understanding of coding, regulatory, and intronic segments. The platform incorporates an automated bioinformatics pipeline and medical expert review, leveraging CENTOGENE’s vast bio databank compiled from data from about 700,000 patients across more than 120 countries. This comprehensive dataset significantly enhances the identification of disease-causing variants, such as those linked to spinal muscular atrophy and Parkinson’s disease.

Who Are The Established Players Within The Genome Sequencing Market?

Major companies operating in the genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMérieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc., CENTOGENE N.V., Bioneer Corporation, Strand Life Sciences Pvt Ltd., Nebula Genomics

Get The Full Genome Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/genome-sequencing-global-market-report

Which Region Accounts For The Largest Portion Of The Genome Sequencing Market?

North America was the largest region in the genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Genome Sequencing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/genome-sequencing-global-market-report

Browse Through More Reports Similar to the Global Genome Sequencing Market 2026, By The Business Research Company

Genome Editing Or Genome Engineering Market Report 2026

https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Single Cell Genome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Whole Genome And Exome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model